MiR-202-3p was also shown to mediate resistance to doxorubicin through regulation via PI3K/AKT signaling [70]; however, the role of miR-202 have not been investigated in brain metastasis of breast cancer cells. This evidence concerns the gene AKT1 and breast carcinoma.